Wellington Biomedical Innovation Master Investors (Cayman) II L.P. - Insider Non-Derivative Transactions at MBX Biosciences, Inc. (MBX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 16, 2024, Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s relationship to MBX Biosciences, Inc. (MBX) is TenPercentOwner, and currently has 1,790,122 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MBX insiders.

Data Source: SEC.
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. - Insider Non-Derivative Transactions of MBX Common Stock
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. - Insider Non-Derivative Transactions at MBX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 17, 2024 C -- (Common Stock) 1386335 0 1386335
Sep 17, 2024 C -- (Common Stock) 403787 0 1790122